Smartwatches in the assessment of heart failure patients in epidemiology and pathophysiology studies: A scoping review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39905203/
A limited number of studies with smartwatches (SWs) investigated their potential in the field of heart failure (HF). The aim of this scoping review is to understand the extent of...
Smartwatches show potential for heart failure management by providing objective activity data, aiding NYHA classification, and supporting outpatient care. Accuracy varies by metric, but patient adherence and cardiologist acceptance are promising.
Multidisciplinary cardiorenal program for heart failure patients: Improving outcomes through comprehensive care - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39824245/
The cardiorenal program (CRP), implemented within a specialized heart failure and kidney disease clinic, encompasses a multidisciplinary approach to the management of patients with heart failure and kidney disease. It...
The Cardiorenal Program (CRP) is a multidisciplinary clinic-based approach for heart failure and kidney disease, optimizing therapy through comprehensive care, diagnostics, and patient education, with performance indicators to enhance outcomes.
Adeno-Associated Viruses as Gene Delivery Tools for Diabetic Heart Disease and Failure: Key Considerations for Clinicians and Preclinical Researchers - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39818494/
Diabetes is becoming more common worldwide, and people with diabetes are twice as likely to experience heart problems compared to those without diabetes. These cardiovascular complications are the foremost cause...
Gene therapy using adeno-associated viral vectors is being explored for diabetic cardiomyopathy, a form of heart failure in diabetes. This review discusses progress, challenges, and experimental considerations in developing targeted treatments.
SGLT2 inhibitors reduce ventricular arrhythmias and sudden cardiac death in heart failure patients, with benefits persisting in long-term follow-up. Future trials are needed to confirm these cardioprotective effects.
Enhancing clinical service design for multimorbidity management: A comprehensive approach to joined-up care for diabetes, chronic kidney disease, and heart failure - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38978167/
A CKM service has the potential to increase the uptake of cardiac and renal protective medications as well as optimising metabolic care, increase capacity in both primary and secondary care,...
Multimorbidity challenges holistic care delivery, especially in CKM syndrome. Integrated, patient-centered care with interdisciplinary teams, telehealth, and policy reforms can optimize outcomes, enhance access, and improve quality of life for patients.